Skip to main content

Peer Review reports

From: Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study

Original Submission
17 Sep 2020 Submitted Original manuscript
29 Sep 2020 Author responded Author comments - Hiroaki Nomoto
Resubmission - Version 2
29 Sep 2020 Submitted Manuscript version 2
26 Oct 2020 Reviewed Reviewer Report
28 Oct 2020 Reviewed Reviewer Report
25 Nov 2020 Author responded Author comments - Hiroaki Nomoto
Resubmission - Version 3
25 Nov 2020 Submitted Manuscript version 3
2 Dec 2020 Author responded Author comments - Hiroaki Nomoto
Resubmission - Version 4
2 Dec 2020 Submitted Manuscript version 4
Publishing
7 Dec 2020 Editorially accepted
14 Dec 2020 Article published 10.1186/s12876-020-01573-9

You can find further information about peer review here.

Back to article page